default author photo

claudio zamagni

Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna

Italy

  • Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna

SCHOLARLY PAPERS

2

DOWNLOADS

129

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Contralateral Prophylactic Mastectomy and Oophorectomy Increase the Survival in Brca-Related Breast Cancer: The Italian Mutina Study

Number of pages: 32 Posted: 08 May 2024
Laura Cortesi, Giulia Cortesi, Marta Venturelli, Angela Toss, Elena Barbieri, Fabio Tamburrano, Antonino Musolino, Ugo De Giorgi, Giancarlo Bisagni, Valentina Arcangeli, claudio zamagni, Luigi Cavanna and Massimo Dominici
Università di Modena e Reggio Emilia, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital of Parma, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) - Clinical and Experimental Oncology Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 81 (816,709)

Abstract:

Loading...

BRCA1, BRCA2, Contralateral Prophylactic Mastectomy, overall survival

2.

Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the Fda Adverse Event Reporting System

Number of pages: 22 Posted: 15 Nov 2023
Sara Cecco, Stefano Puligheddu, Michele Fusaroli, Lorenzo Gerratana, Miao Yan, claudio zamagni, Fabrizio De Ponti and emanuel raschi
Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, University of Bologna, University of Bologna, University of Udine - Deparment of Medicine (DAME), Central South University - Department of Pharmacy, Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna and University of Bologna
Downloads 48 (1,109,210)

Abstract:

Loading...

Antibody-drug conjugates, adverse event, pharmacovigilance, trastuzumab-deruxtecan, trastuzumab-emtansine, Sacituzumab govitecan, disproportionality analysis